Nobel Biocare signs syndicated loan facility
March 18, 2009 | by Nobel Biocare
Reading time: 1 minute
March 18, 2009, Nobel Biocare announced today the closing of a EUR 330 million committed syndicated banking facility with 6 international banks and a maturity of 3 years. The facility is designed to optimize current funding and serves also as a backup line to increase the company’s financial flexibility going forward.
Dirk Kirsten, CFO, said: “In the current financial markets environment the successful closing of such a transaction is an important achievement. This is testimony of our leading market position with intact long-term perspectives, our strong balance sheet and a strong operating cash flow in 2008.”
Editor's note: Image rights belong to the respective publisher.
Conclusion of this article: « Nobel Biocare signs syndicated loan facility »
Source: Nobel Biocare, Press release